Literature DB >> 9569208

Expression of the factor VII activating protease, hepsin, in situ in renal cell carcinoma.

L R Zacharski, D L Ornstein, V A Memoli, S M Rousseau, W Kisiel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9569208

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  7 in total

1.  Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers.

Authors:  Sylvia Herter; Derek E Piper; Wade Aaron; Timothy Gabriele; Gene Cutler; Ping Cao; Ami S Bhatt; Youngchool Choe; Charles S Craik; Nigel Walker; David Meininger; Timothy Hoey; Richard J Austin
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

2.  Phenotypic analysis of mice lacking the Tmprss2-encoded protease.

Authors:  Tom S Kim; Cynthia Heinlein; Robert C Hackman; Peter S Nelson
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

3.  Identification and characterization of small-molecule inhibitors of hepsin.

Authors:  John R Chevillet; Gemma J Park; Antonio Bedalov; Julian A Simon; Valeri I Vasioukhin
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

4.  Mouse matriptase-2: identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues.

Authors:  John D Hooper; Luisa Campagnolo; Goodarz Goodarzi; Tony N Truong; Heidi Stuhlmann; James P Quigley
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

5.  Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model.

Authors:  Jiangyong Miao; David Mu; Burce Ergel; Rajasekhar Singavarapu; Zhenfeng Duan; Scott Powers; Esther Oliva; Sandra Orsulic
Journal:  Int J Cancer       Date:  2008-11-01       Impact factor: 7.396

6.  Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival.

Authors:  Mikko Pelkonen; Kaisa Luostari; Maria Tengström; Hermanni Ahonen; Bozena Berdel; Vesa Kataja; Ylermi Soini; Veli-Matti Kosma; Arto Mannermaa
Journal:  BMC Cancer       Date:  2015-05-27       Impact factor: 4.430

7.  High Hepsin expression predicts poor prognosis in Gastric Cancer.

Authors:  Mingming Zhang; Junjie Zhao; Wenyi Tang; Yanru Wang; Peike Peng; Lili Li; Shushu Song; Hao Wu; Can Li; Caiting Yang; Xuefei Wang; Chunyi Zhang; Jianxin Gu
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.